Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Jazz Pharmaceuticals PLC

+ Add to Watchlist

JAZZ:US

183.0600 USD 2.2800 1.26%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Jazz Pharmaceuticals PLC (JAZZ)

Open: 181.1400 Day's Range: 180.9400 - 184.1000 Volume: 366,865
Previous Close: 180.7800 52wk Range: 131.3600 - 191.0050 1-Yr Rtn: +35.23%

Stock Chart for JAZZ

No chart data available.
  • JAZZ:US 183.0600
  • 1D
  • 1M
  • 1Y
180.7800
Interactive JAZZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JAZZ

Current P/E Ratio (ttm) 37.4191
Estimated P/E(12/2015) 18.9268
Relative P/E vs. SPX 1.9916
Earnings Per Share (USD) (ttm) 4.8922
Est. EPS (USD) (12/2015) 9.6720
Est. PEG Ratio 1.0231
Market Cap (M USD) 11,178.92
Shares Outstanding (M) 61.07
30 Day Average Volume 486,459
Price/Book (mrq) 8.5644
Price/Sale (ttm) 8.9392
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JAZZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for JAZZ

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Bruce C CozaddChairman/CEO/Co-FounderRussell J CoxExec VP/COO
Suzanne Sawochka HooperExec VP/General CounselRobert McKagueSenior VP/Chief Compliance Officer
More Company Profile & Key Executives for JAZZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil